Your browser doesn't support javascript.
loading
Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated gastroenteropancreatic neuroendocrine tumors.
Hoffman, Samantha E; Dowrey, Todd W; Villacorta Martin, Carlos; Bi, Kevin; Titchen, Breanna; Johri, Shreya; DelloStritto, Laura; Patel, Miraj; Mackichan, Colin; Inga, Stephanie; Chen, Judy; Grimaldi, Grace; Napolitano, Sara; Wakiro, Isaac; Wu, Jingyi; Yeung, Jason; Rotem, Asaf; Sicinska, Ewa; Shannon, Erin; Clancy, Thomas; Wang, Jiping; Denning, Sarah; Brais, Lauren; Besson, Naomi R; Pfaff, Kathleen L; Huang, Ying; Kao, Katrina Z; Rodig, Scott; Hornick, Jason L; Vigneau, Sebastien; Park, Jihye; Kulke, Matthew H; Chan, Jennifer; Van Allen, Eliezer M; Murphy, George J.
Affiliation
  • Hoffman SE; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Dowrey TW; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
  • Villacorta Martin C; Harvard-MIT MD-PhD Program, Harvard Medical School, Boston, MA 02115, USA.
  • Bi K; PhD Program in Biological and Biomedical Sciences, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.
  • Titchen B; Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118, USA.
  • Johri S; Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA 02118, USA.
  • DelloStritto L; Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA 02118, USA.
  • Patel M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Mackichan C; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
  • Inga S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Chen J; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
  • Grimaldi G; PhD Program in Biological and Biomedical Sciences, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.
  • Napolitano S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Wakiro I; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
  • Wu J; PhD Program in Biological and Biomedical Sciences, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.
  • Yeung J; Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA.
  • Rotem A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Sicinska E; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Shannon E; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Clancy T; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Wang J; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Denning S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Brais L; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Besson NR; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Pfaff KL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Huang Y; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Kao KZ; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Rodig S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Hornick JL; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Vigneau S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Park J; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
  • Kulke MH; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Chan J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Van Allen EM; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
  • Murphy GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Sci Adv ; 9(39): eadd9668, 2023 09 29.
Article in En | MEDLINE | ID: mdl-37756410
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Stomach Neoplasms / Neuroendocrine Tumors / Intestinal Neoplasms Limits: Humans Language: En Journal: Sci Adv Year: 2023 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Stomach Neoplasms / Neuroendocrine Tumors / Intestinal Neoplasms Limits: Humans Language: En Journal: Sci Adv Year: 2023 Document type: Article Affiliation country: Estados Unidos